For more than 20 years, Illumina has aspired to improve human health by unlocking the power
of the genome. Now, with more than 3400 patents worldwide and our sequencing-by-synthesis
technology being used to generate over 90% of the world’s sequencing data, we are just
beginning to discover the true impact of genomics in areas we touch, including oncology,
reproductive health, genetic disease, agriculture, microbiology, and beyond.